Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WINSHIP4955-20: Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

NCT04393350 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT04393350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04393350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WINSHIP4955-20: Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 22, 2020
Completion date
December 11, 2026
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, stage iii renal cell cancer ajcc v8, stage iv renal cell cancer ajcc v8